Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Péran P[au]:

Search results

Items: 1 to 50 of 74

1.

Grey Matter changes in treatment-resistant depression during electroconvulsive therapy.

Yrondi A, Nemmi F, Billoux S, Giron A, Sporer M, Taib S, Salles J, Pierre D, Thalamas C, Rigal E, Danet L, Pariente J, Schmitt L, Arbus C, Péran P.

J Affect Disord. 2019 Nov 1;258:42-49. doi: 10.1016/j.jad.2019.07.075. Epub 2019 Jul 31.

PMID:
31382103
2.

Clinical Integration of Automated Processing for Brain Quantitative Susceptibility Mapping: Multi-Site Reproducibility and Single-Site Robustness.

Spincemaille P, Liu Z, Zhang S, Kovanlikaya I, Ippoliti M, Makowski M, Watts R, de Rochefort L, Venkatraman V, Desmond P, Santin MD, Lehéricy S, Kopell BH, Péran P, Wang Y.

J Neuroimaging. 2019 Aug 4. doi: 10.1111/jon.12658. [Epub ahead of print]

PMID:
31379055
3.

Enlarged perivascular spaces and florbetapir uptake in patients with intracerebral hemorrhage.

Raposo N, Planton M, Payoux P, Péran P, Albucher JF, Calviere L, Viguier A, Rousseau V, Hitzel A, Chollet F, Olivot JM, Bonneville F, Pariente J.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2339-2347. doi: 10.1007/s00259-019-04441-1. Epub 2019 Jul 29.

PMID:
31359110
4.

Matching ex vivo MRI With Iron Histology: Pearls and Pitfalls.

De Barros A, Arribarat G, Combis J, Chaynes P, Péran P.

Front Neuroanat. 2019 Jul 3;13:68. doi: 10.3389/fnana.2019.00068. eCollection 2019.

5.

Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.

Arribarat G, Pasternak O, De Barros A, Galitzky M, Rascol O, Péran P.

Parkinsonism Relat Disord. 2019 May 22. pii: S1353-8020(19)30254-8. doi: 10.1016/j.parkreldis.2019.05.033. [Epub ahead of print]

PMID:
31182373
6.

A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy control.

Nemmi F, Pavy-Le Traon A, Phillips OR, Galitzky M, Meissner WG, Rascol O, Péran P.

Neuroimage Clin. 2019;23:101858. doi: 10.1016/j.nicl.2019.101858. Epub 2019 May 13.

7.

Discriminating between neurofibromatosis-1 and typically developing children by means of multimodal MRI and multivariate analyses.

Nemmi F, Cignetti F, Assaiante C, Maziero S, Audic F, Péran P, Chaix Y.

Hum Brain Mapp. 2019 Aug 15;40(12):3508-3521. doi: 10.1002/hbm.24612. Epub 2019 May 11.

PMID:
31077476
8.

Neuroimaging and Neurolaw: Drawing the Future of Aging.

Tigano V, Cascini GL, Sanchez-Castañeda C, Péran P, Sabatini U.

Front Endocrinol (Lausanne). 2019 Apr 8;10:217. doi: 10.3389/fendo.2019.00217. eCollection 2019. Review.

9.

Topological disintegration of resting state functional connectomes in coma.

Malagurski B, Péran P, Sarton B, Vinour H, Naboulsi E, Riu B, Bounes F, Seguin T, Lotterie JA, Fourcade O, Minville V, Ferré F, Achard S, Silva S.

Neuroimage. 2019 Jul 15;195:354-361. doi: 10.1016/j.neuroimage.2019.03.012. Epub 2019 Mar 9.

PMID:
30862533
10.

Neuroimaging Biomarkers at Baseline Predict Electroconvulsive Therapy Overall Clinical Response in Depression: A Systematic Review.

Levy A, Taib S, Arbus C, Péran P, Sauvaget A, Schmitt L, Yrondi A.

J ECT. 2019 Jun;35(2):77-83. doi: 10.1097/YCT.0000000000000570.

PMID:
30628993
11.

Brain network connectivity associated with anticipatory postural control in children and adults.

Cignetti F, Vaugoyeau M, Decker LM, Grosbras MH, Girard N, Chaix Y, Péran P, Assaiante C.

Cortex. 2018 Nov;108:210-221. doi: 10.1016/j.cortex.2018.08.013. Epub 2018 Sep 1.

PMID:
30248609
12.

Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).

Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, Galtier F, Mariano-Goulart D, Champfleur NM, Bars EL, Desmidt T, Lemaire M, Camus V, Santiago-Ribeiro MJ, Cottier JP, Fernandez P, Meyer M, Dousset V, Doumy O, Delhaye D, Capuron L, Leboyer M, Haffen E, Péran P, Payoux P, Arbus C.

Front Psychiatry. 2018 Jul 24;9:326. doi: 10.3389/fpsyt.2018.00326. eCollection 2018.

13.

Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer's Disease Patients.

Guerrier L, Le Men J, Gane A, Planton M, Salabert AS, Payoux P, Dumas H, Bonneville F, Péran P, Pariente J.

J Alzheimers Dis. 2018;65(2):443-453. doi: 10.3233/JAD-180324.

14.

Imaging biomarkers of outcome after radiotherapy for pediatric ependymoma.

Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Padovani L, Jouin A, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Kerr C, Le Prisé E, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Laprie A; French Society for Childhood Cancer (SFCE).

Radiother Oncol. 2018 Apr;127(1):103-107. doi: 10.1016/j.radonc.2018.02.008. Epub 2018 Mar 2.

PMID:
29500084
15.

MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.

Péran P, Barbagallo G, Nemmi F, Sierra M, Galitzky M, Traon AP, Payoux P, Meissner WG, Rascol O.

Mov Disord. 2018 Apr;33(4):600-608. doi: 10.1002/mds.27307. Epub 2018 Feb 23.

PMID:
29473662
16.

Electroconvulsive therapy, depression, the immune system and inflammation: A systematic review.

Yrondi A, Sporer M, Péran P, Schmitt L, Arbus C, Sauvaget A.

Brain Stimul. 2018 Jan - Feb;11(1):29-51. doi: 10.1016/j.brs.2017.10.013. Epub 2017 Oct 19. Review.

PMID:
29111078
17.

Impact of spontaneous intracerebral hemorrhage on cognitive functioning: An update.

Planton M, Raposo N, Danet L, Albucher JF, Péran P, Pariente J.

Rev Neurol (Paris). 2017 Jul - Aug;173(7-8):481-489. doi: 10.1016/j.neurol.2017.06.010. Epub 2017 Aug 31. Review.

PMID:
28838790
18.

Medial thalamic stroke and its impact on familiarity and recollection.

Danet L, Pariente J, Eustache P, Raposo N, Sibon I, Albucher JF, Bonneville F, Péran P, Barbeau EJ.

Elife. 2017 Aug 24;6. pii: e28141. doi: 10.7554/eLife.28141.

19.

Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages.

Raposo N, Planton M, Péran P, Payoux P, Bonneville F, Lyoubi A, Albucher JF, Acket B, Salabert AS, Olivot JM, Hitzel A, Chollet F, Pariente J.

Neurology. 2017 Aug 15;89(7):697-704. doi: 10.1212/WNL.0000000000004228. Epub 2017 Jul 19.

PMID:
28724587
20.

The anatomical scaffold underlying the functional centrality of known cortical hubs.

de Pasquale F, Della Penna S, Sabatini U, Caravasso Falletta C, Peran P.

Hum Brain Mapp. 2017 Oct;38(10):5141-5160. doi: 10.1002/hbm.23721. Epub 2017 Jul 6.

PMID:
28681960
21.

High prevalence of cognitive impairment after intracerebral hemorrhage.

Planton M, Saint-Aubert L, Raposo N, Branchu L, Lyoubi A, Bonneville F, Albucher JF, Olivot JM, Péran P, Pariente J.

PLoS One. 2017 Jun 1;12(6):e0178886. doi: 10.1371/journal.pone.0178886. eCollection 2017.

22.

Neural signature of coma revealed by posteromedial cortex connection density analysis.

Malagurski B, Péran P, Sarton B, Riu B, Gonzalez L, Vardon-Bounes F, Seguin T, Geeraerts T, Fourcade O, de Pasquale F, Silva S.

Neuroimage Clin. 2017 May 6;15:315-324. doi: 10.1016/j.nicl.2017.03.017. eCollection 2017.

23.

Brain Gray Matter MRI Morphometry for Neuroprognostication After Cardiac Arrest.

Silva S, Peran P, Kerhuel L, Malagurski B, Chauveau N, Bataille B, Lotterie JA, Celsis P, Aubry F, Citerio G, Jean B, Chabanne R, Perlbarg V, Velly L, Galanaud D, Vanhaudenhuyse A, Fourcade O, Laureys S, Puybasset L.

Crit Care Med. 2017 Aug;45(8):e763-e771. doi: 10.1097/CCM.0000000000002379.

24.

How specialized are writing-specific brain regions? An fMRI study of writing, drawing and oral spelling.

Planton S, Longcamp M, Péran P, Démonet JF, Jucla M.

Cortex. 2017 Mar;88:66-80. doi: 10.1016/j.cortex.2016.11.018. Epub 2016 Dec 18.

PMID:
28081451
25.

Neural Signature of DCD: A Critical Review of MRI Neuroimaging Studies.

Biotteau M, Chaix Y, Blais M, Tallet J, Péran P, Albaret JM.

Front Neurol. 2016 Dec 16;7:227. doi: 10.3389/fneur.2016.00227. eCollection 2016. Review.

26.

Structural-functional brain changes in depressed patients during and after electroconvulsive therapy.

Yrondi A, Péran P, Sauvaget A, Schmitt L, Arbus C.

Acta Neuropsychiatr. 2018 Feb;30(1):17-28. doi: 10.1017/neu.2016.62. Epub 2016 Nov 23. Review.

PMID:
27876102
27.

Neural changes associated to procedural learning and automatization process in Developmental Coordination Disorder and/or Developmental Dyslexia.

Biotteau M, Péran P, Vayssière N, Tallet J, Albaret JM, Chaix Y.

Eur J Paediatr Neurol. 2017 Mar;21(2):286-299. doi: 10.1016/j.ejpn.2016.07.025. Epub 2016 Aug 12.

PMID:
27546352
28.

Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

Khalifa J, Tensaouti F, Lotterie JA, Catalaa I, Chaltiel L, Benouaich-Amiel A, Gomez-Roca C, Noël G, Truc G, Péran P, Berry I, Sunyach MP, Charissoux M, Johnson C, Cohen-Jonathan Moyal E, Laprie A.

J Neurooncol. 2016 Oct;130(1):181-192. Epub 2016 Aug 8.

PMID:
27502603
29.

Prognostic and predictive values of diffusion and perfusion MRI in paediatric intracranial ependymomas in a large national study.

Tensaouti F, Ducassou A, Chaltiel L, Sevely A, Bolle S, Muracciole X, Coche-Dequant B, Alapetite C, Supiot S, Huchet A, Bernier V, Claude L, Bertozzi-Salamon AI, Liceaga S, Lotterie JA, Péran P, Payoux P, Laprie A; radiotherapy committee of the French Society for Childhood Cancer (SFCE).

Br J Radiol. 2016 Oct;89(1066):20160537. doi: 10.1259/bjr.20160537. Epub 2016 Aug 23.

30.

Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus.

Pergola G, Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J.

Neurology. 2016 May 17;86(20):1928. doi: 10.1212/WNL.0000000000002730. No abstract available.

PMID:
27185898
31.

Importance of Multimodal MRI in Characterizing Brain Tissue and Its Potential Application for Individual Age Prediction.

Cherubini A, Caligiuri ME, Peran P, Sabatini U, Cosentino C, Amato F.

IEEE J Biomed Health Inform. 2016 Sep;20(5):1232-9. doi: 10.1109/JBHI.2016.2559938. Epub 2016 Apr 27.

PMID:
27164612
32.

Functional magnetic resonance imaging in disorders of consciousness: preliminary results of an innovative analysis of brain connectivity.

De Pasquale F, Caravasso CF, Péran P, Catani S, Tuovinen N, Sabatini U, Formisano R.

Funct Neurol. 2015 Jul-Sep;30(3):193-201.

33.

Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation.

Khalifa J, Tensaouti F, Chaltiel L, Lotterie JA, Catalaa I, Sunyach MP, Ibarrola D, Noël G, Truc G, Walker P, Magné N, Charissoux M, Ken S, Peran P, Berry I, Moyal EC, Laprie A.

Eur Radiol. 2016 Nov;26(11):4194-4203. Epub 2016 Feb 2.

PMID:
26843012
34.

Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage.

Eustache P, Nemmi F, Saint-Aubert L, Pariente J, Péran P.

J Alzheimers Dis. 2016;50(4):1035-50. doi: 10.3233/JAD-150353.

35.

Brain tissues atrophy is not always the best structural biomarker of physiological aging: A multimodal cross-sectional study.

Cherubini A, Caligiuri ME, Péran P, Sabatini U, Cosentino C, Amato F.

Conf Proc IEEE Eng Med Biol Soc. 2015;2015:5436-40. doi: 10.1109/EMBC.2015.7319621.

PMID:
26737521
36.

Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.

Barbagallo G, Sierra-Peña M, Nemmi F, Traon AP, Meissner WG, Rascol O, Péran P.

Mov Disord. 2016 Mar;31(3):325-34. doi: 10.1002/mds.26471. Epub 2015 Dec 17.

PMID:
26676922
37.

Thalamic amnesia after infarct: The role of the mammillothalamic tract and mediodorsal nucleus.

Danet L, Barbeau EJ, Eustache P, Planton M, Raposo N, Sibon I, Albucher JF, Bonneville F, Peran P, Pariente J.

Neurology. 2015 Dec 15;85(24):2107-15. doi: 10.1212/WNL.0000000000002226. Epub 2015 Nov 13.

38.

Disruption of posteromedial large-scale neural communication predicts recovery from coma.

Silva S, de Pasquale F, Vuillaume C, Riu B, Loubinoux I, Geeraerts T, Seguin T, Bounes V, Fourcade O, Demonet JF, Péran P.

Neurology. 2015 Dec 8;85(23):2036-44. doi: 10.1212/WNL.0000000000002196. Epub 2015 Nov 11.

39.

Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.

Ken S, Deviers A, Filleron T, Catalaa I, Lotterie JA, Khalifa J, Lubrano V, Berry I, Péran P, Celsis P, Moyal EC, Laprie A.

J Neurooncol. 2015 Sep;124(3):465-73. doi: 10.1007/s11060-015-1860-8. Epub 2015 Jul 19.

PMID:
26189058
40.

Finding my own way: an fMRI single case study of a subject with developmental topographical disorientation.

Nemmi F, Bianchini F, Piras F, Péran P, Palermo L, Piccardi L, Sabatini U, Guariglia C.

Neurocase. 2015;21(5):573-83. doi: 10.1080/13554794.2014.960424. Epub 2014 Oct 3.

PMID:
25279725
41.

Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis.

Nemmi F, Sabatini U, Rascol O, Péran P.

Neurobiol Aging. 2015 Jan;36(1):424-33. doi: 10.1016/j.neurobiolaging.2014.07.010. Epub 2014 Jul 23.

PMID:
25174648
42.

Insight on AV-45 binding in white and grey matter from histogram analysis: a study on early Alzheimer's disease patients and healthy subjects.

Nemmi F, Saint-Aubert L, Adel D, Salabert AS, Pariente J, Barbeau EJ, Payoux P, Péran P.

Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1408-18. doi: 10.1007/s00259-014-2728-4. Epub 2014 Feb 27.

43.

Comparison between PET template-based method and MRI-based method for cortical quantification of florbetapir (AV-45) uptake in vivo.

Saint-Aubert L, Nemmi F, Péran P, Barbeau EJ, Payoux P, Chollet F, Pariente J.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):836-43. doi: 10.1007/s00259-013-2656-8. Epub 2013 Dec 19.

44.

Supplementary motor area activation is impaired in severe traumatic brain injury parkinsonism.

Péran P, Catani S, Falletta Caravasso C, Nemmi F, Sabatini U, Formisano R.

J Neurotrauma. 2014 Apr 1;31(7):642-8. doi: 10.1089/neu.2013.3103.

PMID:
24168468
45.

Cortical florbetapir-PET amyloid load in prodromal Alzheimer's disease patients.

Saint-Aubert L, Barbeau EJ, Péran P, Nemmi F, Vervueren C, Mirabel H, Payoux P, Hitzel A, Bonneville F, Gramada R, Tafani M, Vincent C, Puel M, Dechaumont S, Chollet F, Pariente J.

EJNMMI Res. 2013 Jun 3;3(1):43. doi: 10.1186/2191-219X-3-43.

46.

Affective decision making under uncertainty during a plausible aviation task: an fMRI study.

Causse M, Péran P, Dehais F, Caravasso CF, Zeffiro T, Sabatini U, Pastor J.

Neuroimage. 2013 May 1;71:19-29. doi: 10.1016/j.neuroimage.2012.12.060. Epub 2013 Jan 9.

PMID:
23313780
47.

The connectivity of functional cores reveals different degrees of segregation and integration in the brain at rest.

de Pasquale F, Sabatini U, Della Penna S, Sestieri C, Caravasso CF, Formisano R, Péran P.

Neuroimage. 2013 Apr 1;69:51-61. doi: 10.1016/j.neuroimage.2012.11.051. Epub 2012 Dec 6.

PMID:
23220493
48.

Influence of white matter fiber orientation on R2* revealed by MRI segmentation.

de Pasquale F, Cherubini A, Péran P, Caltagirone C, Sabatini U.

J Magn Reson Imaging. 2013 Jan;37(1):85-91. doi: 10.1002/jmri.23801. Epub 2012 Sep 17.

PMID:
22987315
49.

Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI study.

Péran P, Nemmi F, Méligne D, Cardebat D, Peppe A, Rascol O, Caltagirone C, Demonet JF, Sabatini U.

Brain Lang. 2013 Jun;125(3):324-9. doi: 10.1016/j.bandl.2012.06.001. Epub 2012 Jul 25.

PMID:
22841350
50.

MR, (18)F-FDG, and (18)F-AV45 PET correlate with AD PSEN1 original phenotype.

Saint-Aubert L, Payoux P, Hannequin D, Barbeau EJ, Campion D, Delisle MB, Tafani M, Viallard G, Péran P, Puel M, Chollet F, Demonet JF, Pariente J.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):91-4. doi: 10.1097/WAD.0b013e318251d87c.

PMID:
22517194

Supplemental Content

Support Center